Abstract
Most cancer drugs are water-insoluble, untargeted, and have high side effects. In order to overcome these limitations, the development of carrier systems based on biocompatible nanoparticles (NPs) for the intracellular delivery of bioactive drugs has attracted attention in modern nanomedicine. Nanocarriers composed of calcium phosphates (CaPs) stand out due to their unique properties, suc…